Heliox (a mixture of Helium and Oxygen) can reduce the work of breathing in patients with airway stenosis by modifying turbulent flow into laminar flow. The aim of this study was to analyze the effect of Heliox versus conventional oxygen therapy in patients with lower airway stenosis on muscular effort measured by electromyography and diaphragmatic ultrasound, thoracoabdominal synchrony assessed with plethysmographic bands, dyspnea, stridor, oxygen saturation, transcutaneous carbon dioxide value, blood pressure, heart rate and respiratory rate.
Lower airway stenosis results in increased work of breathing with stridor and dyspnea, as a consequence of the increased resistances caused by the reduction in airway diameter. Airway resistance also depends on the length of the airway and the type of gas flow. Heliox (a mixture of Helium and Oxygen) is a gas less dense than air, which can change the flow from turbulent to laminar, reducing airway resistance by 20 to 40%, and therefore decreasing the work of breathing. Heliox is an inert gas that does not react with biological membranes, so there are few complications associated with its use, the most relevant being hypoxemia when fixed mixtures are not used and the the fraction of inspired oxygen (FiO2) supplied is less than 21%. The aim of the study was to evaluate if during the perioperative period of lower airway stenosis the administration of Heliox compared to oxygen could reduce the work of breathing and improve dyspnea. For this purpose, patients were treated for 30 minutes with Heliox (fixed mixture of 70% helium and 30% oxygen) using a non rebreather mask or reservoir bag versus 30 minutes with oxygen 31% using a Venturi mask.
Study Type
OBSERVATIONAL
Enrollment
18
Marta Corral Blanco
Madrid, Spain
Changes in Neural Ventilatory Drive (%):
Percentage over the Root Mean Square peak for parasternal electromyography (EMG): averaged of the square root of the peak value and the area under the curve of parasternal EMG (%RootMeanSquare) adjusted for respiratory frequency, as a surrogate of diaphragmatic EMG, and sternocleidomastoid EMG, which will give us information on accessory muscle activation.
Time frame: 30 minutes with Heliox and 30 minutes with Oxygen 31%
Diaphragmatic excursion assessed with ultrasound
Assessment of muscular effort by measuring the diaphragmatic excursion (mm) at tidal volume and at vital capacity.
Time frame: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
Thickening fraction of the diaphragm assessed by ultrasound
Assessment of muscular effort by measuring the thickening fraction of the diaphragm in the apposition zone (%).
Time frame: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
Changes in thoracoabdominal synchrony
Assessment of thoracoabdominal synchrony using thoracic and abdominal belts by calculating the phase angle with the Lissajoux loop method (plotting abdominal motion on the x-axis against thoracic motion on the y-axis).
Time frame: Phase angle was calculated from 10 consecutive breaths at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Borg Scale Dyspnea evolution (points)
Degree of dyspnea will be determined by this validated scale with a result between 1 and 10 points.0: Not at all 0.5: Very, very light (hardly noticeable) 1: Very light, 2: Light, 3: Moderate , 4: Somewhat intense, 5: Intense, 6: Between 5 and 7, 7: Very intense, 8: Between 7 and 9, 9: Very, very intense (almost maximum ), 10: Maximum
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Oxygen saturation
Measured by pulse-oximetry
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Transcutaneous partial pressure of carbon dioxide
Transcutaneous monitor uses a noninvasive technique to measure the skin-surface partial pressure of carbon dioxide (PtcCO2)
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Blood pressure
Non-invasive measurement with a sphygmomanometer
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Heart rate
number of beats per minute
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Respiratory rate
Number of breaths per minute
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.